S2103 Adrenal tissue transplantAdrenal tissue transplant to brain
Status I: not valid for Medicare (Medicare uses another code).
1 of 1 payer prior-auth lists that name S2103 require prior authorization or set conditions: Rocky Mountain Health Plans.
| Payer | Plan | State | Prior auth | Conditions | Since | Source |
|---|---|---|---|---|---|---|
| Rocky Mountain Health Plans | Rocky Mountain Health Plans CHP+ | CO | prior auth required | Oct 1, 2026 | Rocky Mountain Children’s Health Plan - prior authorization Effective October 1, 2026 |
S2103 appears in 4 coverage policies from Anthem, Blue Cross & Blue Shield of Rhode Island, BlueCross BlueShield of South Carolina, Capital Blue Cross.
| Payer | Policy | Role in policy | Reviewed | Document |
|---|---|---|---|---|
| Anthem | Cell Transplantation (Mesencephalic, Adrenal-Brain and Fetal Xenograft) (TRANS.00004) | unproven / investigational | Feb 19, 2026 | payer document |
| Blue Cross & Blue Shield of Rhode Island | Adrenal-to-Brain Transplantation | not covered | Feb 18, 2026 | payer document |
| BlueCross BlueShield of South Carolina | Cell Transplantation (Mesencephalic, Adrenal-Brain and Fetal Xenograft) (CAM 075) | listed, no stance | Mar 1, 2026 | payer document |
| Capital Blue Cross | Experimental and Investigational Procedures (MP 4.002) Procedure codes: Miscellaneous | listed, no stance | Sep 1, 2026 | payer document |
Prior authorization required or conditional in IN.
From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.